CovidResearchTrials by Shray Alag

CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)

Observational cohort study on the natural history of hospitalized SARS-COV-2 patients.Wiki

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation


Correlated Drug Terms (2)

Name (Synonyms) Correlation
drug737 Continuation of ARB/ACEI Wiki 1.00
drug906 Discontinuation of ARB/ACEI Wiki 1.00

Correlated MeSH Terms (1)

Name (Synonyms) Correlation
D018352 Coronavirus Infections NIH 0.04

Correlated HPO Terms (0)

Name (Synonyms) Correlation

There is one clinical trial.

Clinical Trials

1 Observational Cohort Study on the Natural History of Hospitalized SARS-COV-2 Patients: the STORM Trial

This is an observational study. The aim is to describe the natural history and clinical evolution over time of hospitalized patients affected by Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-COV-2) infection, including the genetic pathology of the disease and improve therapeutic procedures.

NCT04424992 Sars-CoV2 Other: Observational cohort study on the natural history of hospitalized SARS-COV-2 patients.

Primary Outcomes

Description: Description over time of hospitalized patients suffering from SARS-COV-2 infection to better understand the pathogenesis of the disease and improve the controls and therapeutic procedures.

Measure: Covid19 infection clinical evolution

Time: Until patient discharge from the hospital (approximately 1 year)

Secondary Outcomes

Description: Identify risk factors for intra-hospital mortality in hospital wards COVID + patients.

Measure: Risk factors for intra-hospital mortality

Time: Until patient discharge from the hospital (approximately 1 year)

Description: Assess the impact of a fragility index (IF) on the clinical course of COVID + patients.

Measure: The impact of a fragility index (IF)

Time: Until patient discharge from the hospital (approximately 1 year)

Description: Build a prognostic score through which it is possible define a stratification that orients, according to the state of hospitalization, the therapeutic choices.

Measure: Prognostic score

Time: Until patient discharge from the hospital (approximately 1 year).

Description: Differentiate the lung sequelae related to the evolution of viral damage from those of cheater / volutrauma connected to non-invasive (NIV-CPAP) or invasive (MV) ventilation methods.

Measure: The lung sequelae of SARS-COV-2 pneumonia

Time: Until patient discharge from the hospital (approximately 1 year)

Description: Assess the accuracy of IF in elderly patients in terms of clinical outcomes compared to one clinical evaluation based on age and co-morbidity.

Measure: The accuracy of IF in elderly patients

Time: Until patient discharge from the hospital (approximately 1 year)

Description: Describe the anomalies of the coagulation system, which appear on patients affected by SARS-COV-2 pneumonia.

Measure: Coagulation system anomalies

Time: Until patient discharge from the hospital (approximately 1 year)

Description: Description of the impact of the prone position in terms of increased oxygenation of the patient suffering from SARS-COV-2 pneumonia as an index lung recruitment.

Measure: The impact of the prone position on the oxygenation

Time: Until patient discharge from the hospital (approximately 1 year)

No related HPO nodes (Using clinical trials)